[Twelve years experience with irgapyrin. Closing remarks to the comments by C. M. Hasselmann].
D000632:Aminopyrine / Q000008:administration & dosage / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010653:Phenylbutazone / Q000008:administration & dosage / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D000632:Aminopyrine; D010653:Phenylbutazone
Zwölf Jahre Erfahrungen mit Irgapyrin Schlusswort zu den Bemerkungen von C. M. Hasselmann.